Two recent stories in the newspapers have underscored the scandal of thyroid treatment today. This occurred not long after the decision by the UK's General Medical Council (GMC) the regulatory bod ...
The different approaches of the UK and US drug regulators have been noted more than once in this column. A current case in point concerns the thyroid drugs and, in particular, thyroxine sodium, m ...